These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 26383234)

  • 1. Mechanisms underlying the formation of induced pluripotent stem cells.
    González F; Huangfu D
    Wiley Interdiscip Rev Dev Biol; 2016; 5(1):39-65. PubMed ID: 26383234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of somatic cell reprogramming.
    Wang Y; Bi Y; Gao S
    Curr Opin Genet Dev; 2017 Oct; 46():156-163. PubMed ID: 28823984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
    Walia B; Satija N; Tripathi RP; Gangenahalli GU
    Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation dynamics in human induced pluripotent stem cells.
    Nishino K; Umezawa A
    Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
    Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
    Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
    Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
    Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotency-regulating networks provide basis for reprogramming.
    Aksoy I; Stanton LW
    Curr Mol Med; 2013 Jun; 13(5):695-706. PubMed ID: 23642069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic Cell Reprogramming Informed by the Oocyte.
    Gonzalez-Munoz E; Cibelli JB
    Stem Cells Dev; 2018 Jul; 27(13):871-887. PubMed ID: 29737235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-mediated somatic cell reprogramming.
    Kuo CH; Ying SY
    J Cell Biochem; 2013 Feb; 114(2):275-81. PubMed ID: 22961769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
    El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
    Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.
    Ruiz S; Diep D; Gore A; Panopoulos AD; Montserrat N; Plongthongkum N; Kumar S; Fung HL; Giorgetti A; Bilic J; Batchelder EM; Zaehres H; Kan NG; Schöler HR; Mercola M; Zhang K; Izpisua Belmonte JC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16196-201. PubMed ID: 22991473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
    Hu C; Li L
    Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A developmental framework for induced pluripotency.
    Takahashi K; Yamanaka S
    Development; 2015 Oct; 142(19):3274-85. PubMed ID: 26443632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of small molecules on cell reprogramming.
    Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J
    Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.